- Home
- LEDS vs BCTX Comparison
LEDS vs BCTX Comparison
Compare LEDS & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- BCTX
- Stock Information
- Founded
- LEDS 2005
- BCTX 2014
- Country
- LEDS Taiwan
- BCTX Canada
- Employees
- LEDS N/A
- BCTX N/A
- Industry
- LEDS Semiconductors
- BCTX Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- BCTX Health Care
- Exchange
- LEDS Nasdaq
- BCTX Nasdaq
- Market Cap
- LEDS 20.2M
- BCTX 23.5M
- IPO Year
- LEDS 2010
- BCTX N/A
- Fundamental
- Price
- LEDS $2.16
- BCTX $0.80
- Analyst Decision
- LEDS
- BCTX Strong Buy
- Analyst Count
- LEDS 0
- BCTX 1
- Target Price
- LEDS N/A
- BCTX $32.00
- AVG Volume (30 Days)
- LEDS 47.5K
- BCTX 2.4M
- Earning Date
- LEDS 07-11-2025
- BCTX 06-16-2025
- Dividend Yield
- LEDS N/A
- BCTX N/A
- EPS Growth
- LEDS N/A
- BCTX N/A
- EPS
- LEDS N/A
- BCTX N/A
- Revenue
- LEDS $31,108,000.00
- BCTX N/A
- Revenue This Year
- LEDS N/A
- BCTX N/A
- Revenue Next Year
- LEDS N/A
- BCTX N/A
- P/E Ratio
- LEDS N/A
- BCTX N/A
- Revenue Growth
- LEDS 485.62
- BCTX N/A
- 52 Week Low
- LEDS $0.92
- BCTX $0.69
- 52 Week High
- LEDS $3.16
- BCTX $29.40
- Technical
- Relative Strength Index (RSI)
- LEDS 35.35
- BCTX 14.49
- Support Level
- LEDS $2.27
- BCTX $0.79
- Resistance Level
- LEDS $2.59
- BCTX $3.00
- Average True Range (ATR)
- LEDS 0.16
- BCTX 0.22
- MACD
- LEDS -0.04
- BCTX -0.20
- Stochastic Oscillator
- LEDS 4.92
- BCTX 5.51
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.